EUVIMEDEUVIMED entdecken
Crossref

Adverse events associated with budesonide nasal irrigation reported to the US Food and Drug Administration: 2007 to 2022

Vinay K Rathi, Nicholas W Sawicki, Rodney J Schlosser, Zachary M Soler, George A Scangas, Alan D Workman, Stacey T Gray

International Forum of Allergy & Rhinology · 2024

DOI: 10.1002/alr.23232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Forum of Allergy & Rhinology, 2024. Verfasst von Vinay K Rathi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rhinology and Sinus Surgery, Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina, Charleston, Sout…. Hauptthemen laut MEDLINE: Sinusitis, Rhinitis, Nasal Polyps. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: NIDCD NIH HHS, NIH HHS, National Institute on Deafness and Other Communication Disorders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

KEYPOINTS Between 2007 and 2022, the FDA received 119 US‐based reports mentioning budesonide nasal irrigation. Most reports were submitted by patients and alerted FDA to off‐label usage of budesonide. Notable adverse events reported to the FDA included headache, dyspnea, and blurred vision.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SinusitisRhinitisNasal PolypsUnited StatesHumansBudesonideUnited States Food and Drug AdministrationNasal LavageChronic Disease

Stichwörter der Autor:innen

FDAadverse eventsbudesonidechronic rhinosinusitisirrigationnasal polyposissafety

Substanzen

Budesonide

Autor:innen und Institutionen

  • Division of Rhinology and Sinus Surgery, Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Brown University, Providence, Rhode Island, USA.
  • Department of Surgery, Ralph H. Johnson VA Medical Center, Charleston, South Carolina, USA.
  • Department of Otolaryngology, Harvard Medical, School, Boston, Massachusetts, USA.
  • Department of Otolaryngology - Head and Neck Surgery, Massachusetts Eye & Ear Infirmary, Boston, Massachusetts, USA.

Förderung

  • NIDCD NIH HHS
  • NIH HHS
  • National Institute on Deafness and Other Communication Disorders
  • National Institutes of Health

Zitieren

APA

Rathi, V. K., Sawicki, N. W., Schlosser, R. J., Soler, Z. M., Scangas, G. A., Workman, A. D., & Gray, S. T. (2024). Adverse events associated with budesonide nasal irrigation reported to the US Food and Drug Administration: 2007 to 2022. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.23232

Vancouver

Rathi VK, Sawicki NW, Schlosser RJ, Soler ZM, Scangas GA, Workman AD, et al. Adverse events associated with budesonide nasal irrigation reported to the US Food and Drug Administration: 2007 to 2022. International Forum of Allergy & Rhinology. 2024. doi:10.1002/alr.23232

BibTeX
@article{Rathi2024,
  author = {Rathi, Vinay K and Sawicki, Nicholas W and Schlosser, Rodney J and Soler, Zachary M and Scangas, George A and Workman, Alan D and Gray, Stacey T},
  title = {Adverse events associated with budesonide nasal irrigation reported to the US Food and Drug Administration: 2007 to 2022},
  journal = {International Forum of Allergy & Rhinology},
  year = {2024},
  doi = {10.1002/alr.23232}
}
Kostenlos starten →